Xeris Biopharma Holdings (XERS) Shares Outstanding (Entity) (2020 - 2026)
Xeris Biopharma Holdings (XERS) posted Shares Outstanding (Entity) of 173.59 million for Q2 2026, up 7.7% from 161.22 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2025, Xeris Biopharma Holdings' Shares Outstanding (Entity) came in at 166.22 million, up 11.2% from FY2024.
- Annual Shares Outstanding (Entity) has increased for five consecutive years, with a five-year compound annual growth rate of 31.3% (FY2020 to FY2025).
- In prior years, Xeris Biopharma Holdings' Shares Outstanding (Entity) was 149.43 million in FY2024 (+8.2%), 138.13 million in FY2023 (+1.4%), 136.27 million in FY2022 (+72.4%) and 79.03 million in FY2021 (+85.3%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2020.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 20 quarters, with growth averaging 8.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.3% in Q1 2023 to 121.3% in Q1 2022.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 172.56 million (Q1 2026), 166.22 million (Q4 2025) and 165.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Xeris Biopharma Holdings | 1.66 Bn | 1.22 Bn | 79.59 Mn | 173.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 173.59 Mn |
| Mar 31, 2026 | 172.56 Mn |
| Dec 31, 2025 | 166.22 Mn |
| Sep 30, 2025 | 165.53 Mn |
| Jun 30, 2025 | 161.22 Mn |
| Mar 31, 2025 | 156.01 Mn |
| Dec 31, 2024 | 149.43 Mn |
| Sep 30, 2024 | 149.00 Mn |
| Jun 30, 2024 | 148.94 Mn |
| Mar 31, 2024 | 148.22 Mn |
| Dec 31, 2023 | 138.13 Mn |
| Sep 30, 2023 | 138.07 Mn |
| Jun 30, 2023 | 138.01 Mn |
| Mar 31, 2023 | 137.29 Mn |
| Dec 31, 2022 | 136.27 Mn |
| Sep 30, 2022 | 135.96 Mn |
| Jun 30, 2022 | 135.96 Mn |
| Mar 31, 2022 | 135.53 Mn |
| Dec 31, 2021 | 79.03 Mn |
| Sep 30, 2021 | 66.50 Mn |
API Access
Xeris Biopharma Holdings Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();